Search Results for: US Stem Cell

Why I am still very skeptical about stem cells for autism

stem-cells-for-autism

When patient families reach out to me, one of the most common questions is whether stem cells for autism offer real hope. The short answer at this time remains “no”. Of course, it’s not as simple as just “no” because there isn’t enough data to be sure, but there is reason for major skepticism about […]

Why I am still very skeptical about stem cells for autism Read More »

Will Right-To-Try Morph into Right-To-Profit for Stem Cell Clinics?

FDA-RMAT

On one level a reasonable argument can be made for letting terminally ill patients have a right to try experimental as yet unproven therapies, but in the real world Right-To-Try laws have many downsides. On the whole, they are likely to be negative for patients as a group.  Raising the stakes is a push for

Will Right-To-Try Morph into Right-To-Profit for Stem Cell Clinics? Read More »

Stem cell clinic group, Cell Surgical Network, fires PR back at FDA

Cell-Surgical-Network

The FDA took some big action last week and issued a major statement today on stem cell clinics (see my post here). I asked Dr. Mark Berman of the Cell Surgical Network if he had any statement regarding the recent action and statement from the FDA today that involved flagship network member clinic, California Stem Cell

Stem cell clinic group, Cell Surgical Network, fires PR back at FDA Read More »

Six questions as FDA takes new shot at stem cell clinics

FDA

The FDA issued a historic statement today promising to more clearly define its regulatory policies on stem cell therapies and to take strong action on some stem cell clinics that it views as “bad actors”. I’ve never the FDA use such clear-cut language before. I give big kudos to new FDA Commissioner Scott Gottlieb. It already

Six questions as FDA takes new shot at stem cell clinics Read More »

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte

VC-01-post-implant-final1-e1503703572933, viacyte

It’s a difficult, but very important road to conclusively prove that an investigational stem cell therapy is both safe and effective in order to get final approval FDA or equivalents in other countries. For this reason, it is beneficial to highlight even small, but positive steps forward including encouraging pre-clinical data. Today I’m doing a

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte Read More »

Sign up for our weekly newsletter to stay in touch on stem cells & CRISPR

newsletter

Please sign up for our weekly blog newsletter. This will help you stay up to date on all the latest stem cell news and CRISPR developments. You can sign up for the newsletter below. [wysija_form id=”1″] Also, you can sign up as a registered user of this blog in a few seconds over there at

Sign up for our weekly newsletter to stay in touch on stem cells & CRISPR Read More »

Lawsuit against stem cell clinic StemGenex expands to 5 patients

Stemgenex

The stem cell clinic StemGenex was sued almost a year ago related to allegations about their marketing claims. This proposed class action suit, Moorer v. StemGenex, now includes five named patients involved as one can see from the new fourth amended complaint court document. The five total named patients involved in the suit include four new

Lawsuit against stem cell clinic StemGenex expands to 5 patients Read More »